Organization Profile

You just read:

Oncolytics Biotech® Inc. Meets Primary Endpoint for First Stage of U.S. Phase 2 Squamous Cell Lung Cancer Clinical Trial

News provided by

Oncolytics Biotech Inc.

Sep 13, 2012, 06:30 ET